NT
Neurosense Therapeutics Ltd
🇺🇸XNAS.NRSNUnited StatesHealthcare
$0.74USDup +0.03 (+4.23%)OpenDelayed2:22 PM
Price$0.74+0.03 (+4.23%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- IL0011809592
- CUSIP
- Not reported
Company
- Employees
- 17
- Headquarters
- Herzliya, United States
- CEO
- Mr. Alon Ben-Noon
Market
- Shares outstanding
- 1.9M
- Market cap
- $24.71M
Highlights
- Market cap
- $24.71M
- EPS LTM
- -$5.86calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -0.13calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- Not reported
- Net income
- -$11.13M-8.96%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$3.68M
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.